☆ 4.6 Letter

Homozygous mutation in the cardiac troponin I gene: Clinical heterogeneity in hypertrophic cardiomyopathy

INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY

Volume 168, Issue 2, Pages 1530-1531

Publisher

ELSEVIER IRELAND LTD

DOI: 10.1016/j.ijcard.2012.12.008

Keywords

Hypertrophic cardiomyopathy; Genetics; Homozygous; Cardiac troponin I

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Multidisciplinary Sciences

Discordant clinical features of identical hypertrophic cardiomyopathy twins

Giuliana G. Repetti, Yuri Kim, Alexandre C. Pereira, Jodie Ingles, Mark W. Russell, Neal K. Lakdawala, Carolyn Y. Ho, Sharlene Day, Christopher Semsarian, Barbara McDonough, Steven R. DePalma, Daniel Quiat, Eric M. Green, Christine E. Seidman, J. G. Seidman

Summary: The clinical expression of hypertrophic cardiomyopathy (HCM) is influenced by background genetic variation and environmental factors. A study of 11 pairs of monozygotic HCM twins showed discordant cardiac morphology even among twins with the same pathogenic variant, indicating a significant role for epigenetics and environment in HCM disease progression. Whole genome sequencing analysis did not reveal notable somatic genetic variants to explain the clinical differences in the twins.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

Luis R. Lopes, Soledad Garcia-Hernandez, Massimiliano Lorenzini, Marta Futema, Olga Chumakova, Dmitry Zateyshchikov, Maria Isidoro-Garcia, Eduardo Villacorta, Luis Escobar-Lopez, Pablo Garcia-Pavia, Raquel Bilbao, David Dobarro, Maria Sandin-Fuentes, Claudio Catalli, Blanca Gener Querol, Ainhoa Mezcua, Jose Garcia Pinilla, Torsten Bloch Rasmussen, Ana Ferreira-Aguar, Pablo Revilla-Marti, Maria Teresa Basurte Elorz, Alicia Bautista Paves, Juan Ramon Gimeno, Ana Virginia Figueroa, Raul Franco-Gutierrez, Maria Eugenia Fuentes-Canamero, Marina Martinez Moreno, Martin Ortiz-Genga, Jesus Piqueras-Flores, Karina Analia Ramos, Ainars Rudzitis, Luis Ruiz-Guerrero, Ricardo Stein, Mayte Triguero-Bocharan, Luis de la Higuera, Juan Pablo Ochoa, Dad Abu-Bonsrah, Cecilia Y. T. Kwok, Jacob B. Smith, Enzo R. Porrello, Mohammed M. Akhtar, Joanna Jager, Michael Ashworth, Petros Syrris, David A. Elliott, Lorenzo Monserrat, Perry M. Elliott

Summary: The study identified a low but pathogenic frequency of heterozygous ALPK3tv in patients with HCM, which was confirmed through family co segregation studies. ALPK3tv carriers exhibited a characteristic HCM phenotype, showing different clinical and imaging features compared to patients with sarcomere gene variants.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

Luis R. Lopes, Soledad Garcia-Hernandez, Massimiliano Lorenzini, Marta Futema, Olga Chumakova, Dmitry Zateyshchikov, Maria Isidoro-Garcia, Eduardo Villacorta, Luis Escobar-Lopez, Pablo Garcia-Pavia, Raquel Bilbao, David Dobarro, Maria Sandin-Fuentes, Claudio Catalli, Blanca Gener Querol, Ainhoa Mezcua, Jose Garcia Pinilla, Torsten Bloch Rasmussen, Ana Ferreira-Aguar, Pablo Revilla-Marti, Maria Teresa Basurte Elorz, Alicia Bautista Paves, Juan Ramon Gimeno, Ana Virginia Figueroa, Raul Franco-Gutierrez, Maria Eugenia Fuentes-Canamero, Marina Martinez Moreno, Martin Ortiz-Genga, Jesus Piqueras-Flores, Karina Analia Ramos, Ainars Rudzitis, Luis Ruiz-Guerrero, Ricardo Stein, Mayte Triguero-Bocharan, Luis de la Higuera, Juan Pablo Ochoa, Dad Abu-Bonsrah, Cecilia Y. T. Kwok, Jacob B. Smith, Enzo R. Porrello, Mohammed M. Akhtar, Joanna Jager, Michael Ashworth, Petros Syrris, David A. Elliott, Lorenzo Monserrat, Perry M. Elliott

Summary: The study aimed to determine the frequency of heterozygous truncating ALPK3 variants in patients with hypertrophic cardiomyopathy (HCM) and confirm their pathogenicity through burden testing. The results showed that ALPK3tv carriers had a higher prevalence of apical/concentric patterns of hypertrophy and a short PR interval, indicating a characteristic HCM phenotype. Patients with ALPK3tv also had higher rates of heart failure or cardiac transplantation, with imaging and histopathology revealing extensive myocardial fibrosis and myocyte vacuolation.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Genetics & Heredity

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy

Adam Waring, Andrew Harper, Silvia Salatino, Christopher Kramer, Stefan Neubauer, Kate Thomson, Hugh Watkins, Martin Farrall

Summary: This study introduces methods for gene association and variant interpretation that detect clustering of rare missense variants in Mendelian disease genes, which can enhance disease-gene discovery. The statistical methods presented in this study are more powerful and computationally faster than alternative methods, and can effectively integrate ACMG criteria to provide strong evidence of pathogenicity for variants of uncertain significance.

JOURNAL OF MEDICAL GENETICS (2021)

Add to Collection

Review Physiology

Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation

J. M. Chalovich, L. Zhu, D. Johnson

Summary: Striated muscle contraction is inhibited by several actin associated proteins, and the binding of Ca2+ can relieve this inhibition. Tropomyosin can be positioned in three different states on actin, which are associated with different functional states of the contractile system. Mutants of troponin can stabilize different states and provide tools for studying individual states. The C-terminal region of troponin T plays a unique role in limiting Ca2+ activation.

FRONTIERS IN PHYSIOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Genetic Insights into Primary Restrictive Cardiomyopathy

Andreas Brodehl, Brenda Gerull

Summary: Restrictive cardiomyopathy is a rare cardiac disease with poor clinical prognosis, and there is still limited understanding of its genetic forms and molecular mechanisms.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy

Seitaro Nomura, Minoru Ono

Summary: Cardiomyopathy develops through a combination of genetic and environmental factors. Genetic testing can identify causative genes in about half of the cases and predict clinical prognosis. Genome-wide genetic research is crucial for accurate disease risk assessment, as cardiomyopathy is caused by both single rare variants and combinations of multiple common variants. Single-cell analysis research is advancing rapidly, and the combination of genomic analysis and single-cell molecular profiling is expected to contribute to more detailed stratification of cardiomyopathy.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review

Andrei Dan Radu, Cosmin Cojocaru, Sebastian Onciul, Alina Scarlatescu, Alexandru Zlibut, Alexandrina Nastasa, Maria Dorobantu

Summary: Hypertrophic cardiomyopathy (HCM) is a genetic myocardial disease with poor prognosis. Cardiac resynchronization therapy (CRT) has emerged as a minimally invasive tool for patients with heart failure (HF) to improve symptoms and increase left ventricle (LV) systolic performance. This review assesses the importance of CRT in HCM patients based on current research from various published studies.

BIOMEDICINES (2023)

Add to Collection

Article Multidisciplinary Sciences

Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant

Walter Serra, Giulia Vitetta, Vera Uliana, Federico Barocelli, Valeria Barili, Isabella Allegri, Diego Ardissino, Francesca Gualandi, Antonio Percesepe

Summary: A homozygous variant in the MYH7 gene was identified in a 17-year-old patient, leading to early onset HCM. The variant in a heterozygous state was associated with milder cardiac phenotypes in the affected relatives.

HELIYON (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Changing concepts in heart muscle disease: the evolving understanding of hypertrophic cardiomyopathy

William E. Moody, Perry M. Elliott

Summary: The recognition and improved diagnostic techniques for hypertrophic cardiomyopathy (HCM) have led to earlier and more effective management, resulting in improved life expectancy and quality of life for patients. Advances in molecular genetics and novel therapies offer exciting prospects for the future treatment of HCM.

HEART (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy

Sara Ranjbarvaziri, Kristina B. Kooiker, Mathew Ellenberger, Giovanni Fajardo, Mingming Zhao, Alison Schroer Vander Roest, Rahel A. Woldeyes, Tiffany T. Koyano, Robyn Fong, Ning Ma, Lei Tian, Gavin M. Traber, Frandics Chan, John Perrino, Sushma Reddy, Wah Chiu, Joseph C. Wu, Joseph Y. Woo, Kathleen M. Ruppel, James A. Spudich, Michael P. Snyder, Kevin Contrepois, Daniel Bernstein

Summary: The study found that metabolic signaling disruption and mitochondrial dysfunction are common pathogenic mechanisms in patients with HCM, highlighting potential new drug targets for mitigating the disease by improving metabolic function and reducing mitochondrial injury.

CIRCULATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy

Nicholas A. Marston, Larry Han, Iacopo Olivotto, Sharlene M. Day, Euan A. Ashley, Michelle Michels, Alexandre C. Pereira, Jodie Ingles, Christopher Semsarian, Daniel Jacoby, Steven D. Colan, Joseph W. Rossano, Samuel G. Wittekind, James S. Ware, Sara Saberi, Adam S. Helms, Carolyn Y. Ho

Summary: Patients with childhood-onset hypertrophic cardiomyopathy are more likely to have sarcomeric disease, have a higher risk of life-threatening ventricular arrhythmias, and have a greater need for advanced heart failure therapies.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Myopathic Cardiac Genotypes Increase Risk for Myocarditis

Amy R. Kontorovich, Nihir Patel, Arden Moscati, Felix Richter, Inga Peter, Enkhsaikhan Purevjav, Simina Ramona Selejan, Ingrid Kindermann, Jeffrey A. Towbin, Michael Bohm, Karin Klingel, Bruce D. Gelb

Summary: Impairments in certain cardiac genes may increase the risk of myocarditis in children, as evidenced by more deleterious gene variants found in patients with acute myocarditis. Thirteen genes associated with cardiomyopathy or neuromuscular disorders with cardiac involvement were found to be implicated in the study.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Pediatric Hypertrophic Cardiomyopathy: Exploring the Genotype-Phenotype Association

Minh B. Nguyen, Seema Mital, Luc Mertens, Aamir Jeewa, Mark K. Friedberg, Julien Aguet, Arnon Adler, Christopher Z. Lam, Andreea Dragulescu, Harry Rakowski, Olivier Villemain

Summary: This review examines the association between genetic variations and outcomes in pediatric hypertrophic cardiomyopathy (HCM), discussing current approaches to phenotyping cardiovascular characteristics and exploring potential avenues for improving risk assessment of sudden cardiac death in children with HCM.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Add to Collection

Letter Medicine, General & Internal

Troponin I after Cardiac Surgery and 30-Day Mortality

Felix Hennig, Christoph Knosalla

Summary: Devereaux et al. have contributed to the characterization of appropriate thresholds for defining myocardial damage after cardiac surgery, particularly in relation to the use of different cardioplegic solutions.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Inconsistent discharge diagnoses for young cardiac arrest episodes: insights from a statewide registry

Elizabeth D. Paratz, Alexander van Heusden, Jocasta Ball, Karen Smith, Dominica Zentner, Natalie Morgan, Sarah Parsons, Tina Thompson, Paul James, Vanessa Connell, Andreas Pflaumer, Christopher Semsarian, Jodie Ingles, Dion Stub, Andre La Gerche

Summary: Administrative coding of out-of-hospital cardiac arrest in young patients is heterogeneous, with nearly one-third of diagnoses including neither the cardiac arrest nor any underlying cause. Patients receiving a noninformative diagnosis were more likely to have survived the cardiac arrest or been referred for forensic assessment and had a longer length of stay.

INTERNAL MEDICINE JOURNAL (2023)

Add to Collection

Article Genetics & Heredity

Evaluating a communication aid for return of genetic results in families with hypertrophic cardiomyopathy: A randomized controlled trial

Charlotte Burns, Laura Yeates, Joanna Sweeting, Christopher Semsarian, Jodie Ingles

Summary: Genetic testing for hypertrophic cardiomyopathy is crucial for management, but communication of test results remains a barrier. This study evaluated the knowledge and communication of HCM risk, and found that communication among HCM families is challenging, with a significant number of at-risk relatives not informed of a genetic result.

JOURNAL OF GENETIC COUNSELING (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant

Edgar T. Hoorntje, Charlotte Burns, Luisa Marsili, Ben Corden, Victoria N. Parikh, Gerard J. te Meerman, Belinda Gray, Ahmet Adiyaman, Richard D. Bagnall, Daniela Q. C. M. Barge-Schaapveld, Maarten P. van den Berg, Marianne Bootsma, Laurens P. Bosman, Gemma Correnti, Johan Duflou, Ruben N. Eppinga, Diane Fatkin, Michael Fietz, Eric Haan, Jan D. H. Jongbloed, Arnaud D. Hauer, Lien Lam, Freyja H. M. van Lint, Amrit Lota, Carlo Marcelis, Hugh J. McCarthy, Anneke M. van Mil, Rogier A. Oldenburg, Nicholas Pachter, R. Nils Planken, Chloe Reuter, Christopher Semsarian, Jasper J. van der Smagt, Tina Thompson, Jitendra Vohra, Paul G. A. Volders, Jaap I. van Waning, Nicola Whiffin, Arthur van den Wijngaard, Ahmad S. Amin, Arthur A. M. Wilde, Gijs van Woerden, Laura Yeates, Dominica Zentner, Euan A. Ashley, Matthew T. Wheeler, James S. Ware, J. Peter van Tintelen, Jodie Ingles

Summary: This study investigated the clinical characteristics, genotype, and genetics of arrhythmogenic cardiomyopathy caused by truncating variants in the desmoplakin gene (DSPtv). The results showed that the location of DSPtv and individual disease status were independent risk factors for ventricular arrhythmia. Furthermore, the study found that disease-associated gene variants were more likely to occur in important regions of the DSP gene compared to the control group. This study highlights the importance of gene variants in arrhythmogenic cardiomyopathy and provides critical insights for clinical management.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry

Sarah Abou Alaiwi, Thomas M. Roston, Peter Marstrand, Brian Lee Claggett, Victoria N. Parikh, Adam S. Helms, Jodie Ingles, Rachel Lampert, Neal K. Lakdawala, Michelle Michels, Anjali T. Owens, Joseph W. Rossano, Sara Saberi, Dominic J. Abrams, Euan A. Ashley, Christopher Semsarian, John C. Stendahl, James S. Ware, Erin Miller, Thomas D. Ryan, Mark W. Russell, Sharlene M. Day, Iacopo Olivotto, Christoffer R. Vissing, Carolyn Y. Y. Ho

Summary: A study on children diagnosed with hypertrophic cardiomyopathy (HCM) found that they have a higher risk of developing left ventricular systolic dysfunction (LVSD) compared to adult patients. This study highlights the importance of careful surveillance for LVSD in children with HCM, especially during their transition to adult care.

CIRCULATION (2023)

Add to Collection

Article Genetics & Heredity

Sudden cardiac death in the young: A qualitative study of experiences of family members with cardiogenetic evaluation

Lieke van den Heuvel, Judy Do, Laura Yeates, Charlotte Burns, Chris Semsarian, Jodie Ingles

Summary: Sudden cardiac death (SCD) in young people is a devastating event, often caused by genetic heart diseases. This study explored the experiences of family members who underwent cardiogenetic evaluation after SCD. The results highlighted the importance of coordinated care, including psychological support, to adequately support these families.

JOURNAL OF GENETIC COUNSELING (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy

Rachel Lampert, Michael J. Ackerman, Bradley S. Marino, Matthew Burg, Barbara Ainsworth, Lisa Salberg, Maria Teresa Tome Esteban, Carolyn Y. Ho, Roselle Abraham, Seshadri Balaji, Cheryl Barth, Charles I. Berul, Martijn Bos, David Cannom, Lubna Choudhury, Maryann Concannon, Robert Cooper, Richard J. Czosek, Anne M. Dubin, James Dziura, Benjamin Eidem, Michael S. Emery, N. A. Mark Estes, Susan P. Etheridge, Jeffrey B. Geske, Belinda Gray, Kevin Hall, Kimberly G. Harmon, Cynthia A. James, Ashwin K. Lal, Ian H. Law, Fangyong Li, Mark S. Link, William J. McKenna, Silvana Molossi, Brian Olshansky, Steven R. Ommen, Elizabeth V. Saarel, Sara Saberi, Laura Simone, Gordon Tomaselli, James S. Ware, Douglas P. Zipes, Sharlene M. Day

Summary: This study aimed to determine whether engagement in vigorous exercise is associated with increased risk for ventricular arrhythmias and/or mortality in individuals with hypertrophic cardiomyopathy (HCM). The findings showed that individuals exercising vigorously did not have a higher rate of death or life-threatening arrhythmias compared to those exercising moderately or those who were sedentary. These results may provide useful information for discussions between patients and their doctors regarding exercise participation.

JAMA CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronar y ar ter y disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial

Michael P. Gray, Yemima Berman, Giordano Botta, Stuart M. Grieve, Amy Ho, Jessica Hu, Karice Hyun, Jodie Ingles, Garry Jennings, Gary Kilov, Jean-Frederic Levesque, Peter Meikle, Julie Redfern, Tim Usherwood, Stephen T. Vernon, Stephen J. Nicholls, Gemma A. Figtree, P. P. P. C. A. D. Collaborators N. S. W. PPP CAD Collaborators NSW

Summary: This study aims to use a novel clinical pathway incorporating a coronary artery disease (CAD) polygenic risk score (PRS) to identify individuals with subclinical CAD and triage low or moderate risk individuals for noninvasive coronary imaging, in order to improve risk prediction and treatment decisions. The study will evaluate the ability of the PRS to identify subclinical CAD and examine its impact on risk factor management, pharmacotherapy utilization, and participant experience.

AMERICAN HEART JOURNAL (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

The moral and practical urgency of increasing diversity in genomics

Jodie Ingles, Daniel G. MacArthur

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

The New South Wales Sudden Cardiac Arrest Registry: A Data Linkage Cohort Study

Felicity Leslie, Suzanne R. Avis, Richard D. Bagnall, Jason Bendall, Tom Briffa, Isabel Brouwer, Alexandra Butters, Gemma A. Figtree, Andre La Gerche, Belinda Gray, Lee Nedkoff, Gregory Page, Elizabeth Paratz, Christopher Semsarian, Raymond W. Sy, Lorraine du Toit-Prinsloo, Laura Yeates, Joanna Sweeting, Jodie Ingles

Summary: Sudden cardiac arrest (SCA) in young people aged 1 to 50 years often occurs without symptoms or risk factors. The New South Wales (NSW) Sudden Cardiac Arrest Registry is a retrospective study that aims to identify all SCAs in young people from 2009 through to June 2022. The objective is to determine the incidence, demographic characteristics and causes of SCA in young people. This registry will contribute to a greater understanding of SCA and its impacts.

HEART LUNG AND CIRCULATION (2023)

Add to Collection

Article Genetics & Heredity

TBX20 loss-of-function variants in families with left ventricular non-compaction cardiomyopathy

Yuchen Chang, Julie Wacker, Jodie Ingles, Ivan Macciocca, Ingrid King, Christopher Semsarian, Julie Mcgaughran, Robert G. Weintraub, Richard D. Bagnall

Summary: TBX20 is a cardiac transcription factor associated with atrial septal defects. Loss-of-function variants in TBX20 have been found in families with left ventricular non-compaction cardiomyopathy (LVNC). We report four families with TBX20 loss-of-function variants that segregate with LVNC. Our data strengthen the association between TBX20 loss-of-function variants and LVNC, and support the inclusion of TBX20 in genetic testing for LVNC.

JOURNAL OF MEDICAL GENETICS (2023)

Add to Collection

Article Genetics & Heredity

The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death

Emma S. Singer, Joshua Crowe, Mira Holliday, Julia C. Isbister, Sean Lal, Natalie Nowak, Laura Yeates, Charlotte Burns, Sulekha Rajagopalan, Ivan Macciocca, Ingrid King, Julie Wacker, Jodie Ingles, Robert G. Weintraub, Christopher Semsarian, Richard D. Bagnall

Summary: Our study highlights the significant role of splice-disrupting variants in inherited heart disease, and demonstrates that analysis of blood RNA can confirm splicing outcomes and support classification of variant pathogenicity.

NPJ GENOMIC MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Longitudinal assessment of structural phenotype in Brugada syndrome using cardiac magnetic resonance imaging

Julia C. Isbister, Belinda Gray, Sophie Offen, Laura Yeates, Chris Naoum, Caroline Medi, Hariharan Raju, Christopher Semsarian, Rajesh Puranik, Raymond W. Sy

Summary: This study utilized cardiac magnetic resonance imaging to longitudinally assess patients with Brugada syndrome. It found that structural changes, specifically focal fibrosis, can develop over time in a significant proportion of patients. These findings have implications for understanding the pathological substrate and longitudinal evaluation of Brugada syndrome patients.

HEART RHYTHM O2 (2023)

Add to Collection

Article Health Care Sciences & Services

The Australian Genetic Heart Disease Registry: Protocol for a Data Linkage Study

Alexandra Butters, Bianca Blanch, Anna Kemp-Casey, Judy Do, Laura Yeates, Felicity Leslie, Christopher Semsarian, Lee Nedkoff, Tom Briffa, Jodie Ingles, Joanna Sweeting

Summary: This study aims to link the Australian Genetic Heart Disease (AGHD) Registry with routinely collected health data sets in order to investigate the health care use patterns of individuals with a genetic heart disease and their at-risk relatives. This linked data set will enable the examination of differences in outcomes and health care use due to disease, sex, socioeconomic status, and other factors.

JMIR RESEARCH PROTOCOLS (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.